Navigation Links
Flo-Mist™ Continuous Medication Nebulizer (CMN)

ProductsFlo-Mist™ Continuous Medication Nebulizer (CMN)
Company DHD Healthcare
Item Flo-Mist™ Continuous Medication Nebulizer (CMN)
Features 
  • Auxiliary port --Allows the clinician to add an auxiliary gas flow without recalculating the medication.
  • Rescue Valve --Located in the non-rebreather circuit, a fail-safe one-way valve in the valved Y piece that allows the patient to entrain ambient air should their inspiratory demand exceed the system.
  • Connects directly to flowmeter --Once connected to the flowmeter, Flo-Mist is fully secured and easy to access for refilling.
  • Up to 8 hours of continuous therapy --Flo-Mist delivers medications as well as humidification for any prescribed length of time up to 8 hours.
  • Dosing chart included --Convenient dosing chart included in each package for quick reference.
  • Aerosol and non-rebreather kits --A fast and convenient way to administer therapy in emergency care settings.
  • Standard 22mm aerosol port --Use your existing tubing or purchase Flo-Mist as a kit.
  • Colorful graphics and gradients --Easy to read gradient lines calibrated at 5ml, ensuring precise medication delivery.
Description For delivery of medication as well as humidification, try Flo-Mist™.

Flo-Mist™, is a refillable, closed dilution, high volume, continuous medication nebulizer (CMN), engineered to deliver deep inhalation therapy to patients. Its 200 ml reservoir and jet flow design allow for up to 8 hours of nebulized medication delivery at 25 ml/hr. Particles are delivered within the 3 to 5 micron range. Flo-Mist™ is the product of choice for many different applications.

Flo-Mist's smart design allows clinicians to add an auxiliary flow of air, Oxygen or Heliox through the side port, without the hassle of recalculating the medication dosage.

The versatile Flo-Mist™ is available as a single nebulizer or in aerosol and non-rebreathing mask kits, where everything required for an acute treatment is packaged in one convenient kit.

For patients requiring higher concentrations (> 50%) of oxygen, consider Flo-Mist's non-rebreathing mask kit. Designed to allow Oxygen and Heliox delivery to be controlled, it can safely provide patients with the gas concentrations they need. This kit, complete with built-in rescue valve and reservoir bag, allows the patient to entrain room air should the patient's inspiratory demand exceed the system.

Shipped 10 kits per case.

Not licensed for sale in Canada.
Info 

Related medicine products :

1. Flo-Mist™ Continuous Medication Nebulizer (CMN) - Adult Kits
2. Flo-Mist™ Continuous Medication Nebulizer (CMN) - Pediatric Kits
3. CGMS System Gold Continuous Glucose Monitoring
4. Continuous Wave II Arthroscopy Pump
5. DNA Engine Opticon Continuous Fluorescence Detection System
6. DNA Engine Opticon 2 Continuous Fluorescence Detection System
7. USA Elite System™ Rotating Continuous Flow Resectoscopes
8. Continuous Flow Cystoscopes
9. CAVR (Continuous Arteriovenous Rewarming)
10. OMNI~MAX Heliox Rescue Continuous Nebulizer
11. DexCom™ STS™ Continuous Glucose Monitoring System
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products:
(Date:4/28/2017)... ... April 28, 2017 , ... An April 24th article on Yahoo! Beauty discusses ... with the help of a weight loss surgery. The woman, declaring “I will not hate ... been left following her dramatic weight loss. Dr. Feiz & Associates notes that, while it ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... its new partnership with the Home Care Association of America (HCAOA). This agreement ... Private Duty Accreditation services, as well as discounts on Accreditation University (AU) educational ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to ... since it streamlines the reporting process and provides a familiar interface that does ...
(Date:4/28/2017)... ... ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced today that ... as “stable.” At the same time, the ratings agency cautioned that the company’s rating ... “capital adequacy” thresholds required for its strong rating. , “Horizon is committed to being ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. announced today ... throughout the Northeast U.S. , GlycoMark is the only clinically available blood ... provides a clinically proven one- to two-week measure of hyperglycemic excursions, often related ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017  Cogentix Medical, Inc. (NASDAQ: ... providing the Urology, Uro/Gyn and Gynecology markets with ... Keswani has joined the Company as Senior Vice ... created position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has ...
(Date:4/20/2017)...  RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage ... unmet medical needs, today announced that it will ... development program, based on its proprietary self-delivering RNAi ... (SID) 76 th Annual Meeting.  The SID ... relevant to skin health and disease through education, ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
Breaking Medicine Technology: